Atrás
Rango del Día
$1.57
$1.57
Rango de 52 Semanas
$0.81
$1.85
Volumen
1,000
Promedio 50D / 200D
$1.45
/
$1.37
Cierre Anterior
$1.57
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -13.5 | 0.4 |
| P/B | 4.8 | 2.9 |
| ROE % | -31.6 | 3.9 |
| Net Margin % | -20.8 | 3.8 |
| Rev Growth 5Y % | 12.4 | 10.0 |
| D/E | 2.8 | 0.2 |
Precio Objetivo de Analistas
No hay cobertura de analistas disponible
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2027 |
$0.09
$0.08 – $0.09
|
1.4 B | 1 |
| FY2026 |
$0.05
$0.05 – $0.05
|
1.3 B | 1 |
Puntos Clave
Revenue grew 12.40% annually over 5 years — strong growth
Debt/Equity of 2.79 — high leverage
Negative free cash flow of -158.54M
PEG of 0.13 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.51%
Crecimiento
Revenue Growth (5Y)
12.40%
Revenue (1Y)8.89%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-31.58%
ROIC-4.13%
Net Margin-20.76%
Op. Margin-12.17%
Seguridad
Debt / Equity
2.79
Current Ratio1.47
Interest Coverage-1.18
Valoración
P/E Ratio
-13.49
P/B Ratio4.81
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8.89% | Revenue Growth (3Y) | 10.96% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 12.40% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1.04B | Net Income (TTM) | -214.92M |
| ROE | -31.58% | ROA | -5.92% |
| Gross Margin | 55.45% | Operating Margin | -12.17% |
| Net Margin | -20.76% | Free Cash Flow (TTM) | -158.54M |
| ROIC | -4.13% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2.79 | Current Ratio | 1.47 |
| Interest Coverage | -1.18 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -13.49 | P/B Ratio | 4.81 |
| P/S Ratio | 2.80 | PEG Ratio | 0.13 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.90B | Enterprise Value | 3.87B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 1.04B | 950.73M | 840.83M | 778.64M | 648.73M |
| Net Income | -214.92M | -477.63M | -436.52M | -276.48M | -191.25M |
| EPS (Diluted) | -0.12 | -0.27 | -0.25 | -0.16 | -0.11 |
| Gross Profit | 574.09M | 532.10M | 501.77M | 491.77M | 436.03M |
| Operating Income | -125.98M | -516.17M | -506.57M | -293.62M | -167.14M |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 3.63B | 3.93B | 3.99B | 4.38B | 2.47B |
| Total Liabilities | 2.49B | 2.53B | 2.20B | 2.16B | 1.08B |
| Shareholders' Equity | 603.22M | 757.82M | 1.14B | 1.49B | 1.13B |
| Total Debt | 1.69B | 1.70B | 1.47B | 1.24B | 296.31M |
| Cash & Equivalents | 713.00M | 1.02B | 1.20B | 1.75B | 1.00B |
| Current Assets | 1.74B | 2.01B | 1.94B | 2.39B | 1.48B |
| Current Liabilities | 1.18B | 1.27B | 662.13M | 546.76M | 519.38M |